HLS Therapeutics Inc HLTRF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $2.59
- Day Range
- $2.59–2.59
- 52-Week Range
- $2.45–4.60
- Bid/Ask
- $2.22 / $2.85
- Market Cap
- $82.40 Mil
- Volume/Avg
- 600 / 622
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.37
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 2.14%
Company Profile
HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company products include Clozaril, Vascepa, CSAN Pronto, and others. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, and the United States, and the Rest of the world.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 90
- Website
- https://www.hlstherapeutics.com
Comparables
Valuation
|
Metric
|
HLTRF
|
4577
|
9273
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 11.97 | 6.39 |
Price/Book Value | 0.93 | 0.68 | 1.25 |
Price/Sales | 1.37 | 0.77 | 1.26 |
Price/Cash Flow | 10.17 | 5.75 | 7.90 |
Price/Earnings
HLTRF
4577
9273
Financial Strength
|
Metric
|
HLTRF
|
4577
|
9273
|
|---|---|---|---|
Quick Ratio | 1.11 | 0.82 | 2.84 |
Current Ratio | 1.56 | 2.29 | 4.37 |
Interest Coverage | −2.02 | 197.65 | 646.85 |
Quick Ratio
HLTRF
4577
9273
Profitability
|
Metric
|
HLTRF
|
4577
|
9273
|
|---|---|---|---|
Return on Assets (Normalized) | −8.39% | 5.80% | 15.42% |
Return on Equity (Normalized) | −17.51% | 8.27% | 20.77% |
Return on Invested Capital (Normalized) | −4.77% | 7.32% | 18.17% |
Return on Assets
HLTRF
4577
9273
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Mhcwvbrbhm | Cwgl | $82.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Lwlqkyjb | Ntfkkmj | $75.2 Bil | |||
| Haleon PLC ADR
HLN
| Rfybfbpzb | Vgwq | $41.4 Bil | |||
| Viatris Inc
VTRS
| Zkfnlqxf | Zmtf | $14.4 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Xslxcgdn | Wvdb | $13.7 Bil | |||
| Catalent Inc
CTLT
| Jtvnhfmy | Gfzggh | $10.6 Bil | |||
| Perrigo Co PLC
PRGO
| Zxpxgxdrg | Xpfc | $3.8 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Yftbhczq | Qmzvb | $3.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Klqkvnq | Wmznr | $3.0 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Gmkpfnhbr | Fvw | $2.7 Bil |